Trial intelligence / Profile preview

Suhuang Zhike Capsules for bronchial asthma

ChiCTR2200055367Phase 4Recruiting

Sponsor
Shanghai General Hospital
Start
Jan 2022
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in asthma comparing Experimental group: Suhuang Zhike Capsules with Control group: Suhuang Zhike Capsule placebo (2 arms). Primary endpoint: ACT score. Started Jan 2022; status: recruiting.

02

Drugs

Suhuang Zhike
03

Conditions

asthma

Beyond the preview

Go deeper on ChiCTR2200055367.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200055367.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call